We are live on
!
Find out more
IA
Investor AB Portfolio holdings
AUM
$15.1B
1-Year Est. Return
29.02%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+29.02%
3 Year Est. Return
+79.02%
5 Year Est. Return
+98.76%
10 Year Est. Return
+341.52%
AUM
$2.87B
AUM Growth
+$263M
(+10%)
Cap. Flow
-$19.9M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neuronetics
STIM
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 99.75% |
| 2 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nasdaq
NDAQ
$53.2B
| $2.86B | 99.75% |
58,182,426
| – | – |
|
|
AGRX
2
DELISTED
Agile Therapeutics
AGRX
| $7.3M | 0.25% |
1,755
| – | – |
|
|
3
Neuronetics
STIM
$137M
| – | – |
-1,794,228
| Closed | -$19.9M |
|
Similar funds
MSV
AT
UM
RFC
FCAS
GF
Investor AB's Q1 2021 Portfolio in Review
As of Q1 2021, Investor AB held 3 positions worth $2.87B, up 10% from $2.6B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Investor AB's Q1 2021 filing shows 1 closed position. The largest sale was Neuronetics, an estimated $19.9M.
By sector, the portfolio is most concentrated in Financials at 100% of assets, up from 99% a quarter earlier, followed by Healthcare.
- Investor AB fully exited Neuronetics in Q1 2021, selling an estimated $19.9M.
- Investor AB's ten largest holdings make up 100% of its $2.87B portfolio in Q1 2021.
- Investor AB opened 0 new positions and closed 1 in Q1 2021.
- Investor AB's portfolio value rose 10% quarter-over-quarter to $2.87B.
Based on Investor AB's 13F filing for Q1 2021, filed 17 May 2021.